Weed (BUDZ) Cash from Financing Activities (2010 - 2026)
Weed (BUDZ) posted quarterly Cash from Financing Activities of $29200.0 for Q1 2026, up 134.64% year-over-year from $12444.7 in Q1 2025, and down 80.84% quarter-over-quarter from $152403.0 in Q4 2025.
Weed (BUDZ) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Weed's Cash from Financing Activities history runs 13 years deep, the most recent figure standing at $29200.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 134.64% year-over-year to $29200.0; the TTM figure through Mar 2026 stood at $183603.0 (down 12.97% YoY), while the FY2025 annual figure was $70103.0, down 75.43% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $29200.0, down from $152403.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $281344.0 in Q4 2024, with the low at -$530000.0 in Q3 2023.
- The 5-year median for Cash from Financing Activities is -$10095.0 (2023), against an average of -$22004.6.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 1975.63% in 2024, then sank 743.0% in 2025.
- Weed's Cash from Financing Activities stood at -$39981.0 in 2022, then jumped by 62.48% to -$15000.0 in 2023, then surged by 1975.63% to $281344.0 in 2024, then plunged by 45.83% to $152403.0 in 2025, then plunged by 80.84% to $29200.0 in 2026.
- Business Quant data shows BUDZ's Cash from Financing Activities at $29200.0 in Q1 2026, $152403.0 in Q4 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Weed | 4.08 Mn | 4.08 Mn | - | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,200.00 |
| Mar 31, 2026 | 29,200.00 |
| Dec 31, 2025 | 152,403.00 |
| Dec 31, 2025 | 152,403.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | -84,300.00 |
| Mar 31, 2025 | -84,300.00 |
| Dec 31, 2024 | 281,344.00 |
| Dec 31, 2024 | 281,344.00 |
| Sep 30, 2024 | 18,925.00 |
| Sep 30, 2024 | 18,925.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Dec 31, 2023 | -15,000.00 |
| Sep 30, 2023 | -530,000.00 |
| Sep 30, 2023 | -530,000.00 |